Capital Research Global Investors Nevro Corp Transaction History

Capital Research Global Investors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $94.9 Million - $146 Million	-1,582,704 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $17.3 Million - $25.9 Million	213,670 Added 15.61%	1,582,704 $128 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $30.9 Million - $50.4 Million	302,849 Added 28.4%	1,369,034 $159 Million
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $22.1 Million - $28 Million	156,379 Added 17.19%	1,066,185 $177 Million
Q1 2021 May 14, 2021	BUY	$132.81 - $182.18 $14.6 Million - $20.1 Million	110,086 Added 13.77%	909,806 $127 Million
Q4 2020 Feb 12, 2021	BUY	$138.17 - $184.34 $110 Million - $147 Million	799,720 New	799,720 $138 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.